AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
DO SPECIALISTS DO IT BETTER - THE IMPACT OF SPECIALIZATION ON THE PROCESSES AND OUTCOMES OF CARE FOR CANCER-PATIENTS
Authors: GRILLI R MINOZZI S TINAZZI A LABIANCA R SHELDON TA LIBERATI A
Citation: R. Grilli et al., DO SPECIALISTS DO IT BETTER - THE IMPACT OF SPECIALIZATION ON THE PROCESSES AND OUTCOMES OF CARE FOR CANCER-PATIENTS, Annals of oncology, 9(4), 1998, pp. 365-374
RANDOMIZED COMPARISON BETWEEN SEQUENTIAL MTX-]FU AND SCHEDULE SPECIFIC BIOCHEMICAL MODULATION IN ADVANCED COLORECTAL-CANCER (ACRC)
Authors: SOBERO A FRASSINETI GL GIULANI R CAROTI C RAVAIOLI A LANFRANCO C CAPRIONI F ALGHISI A ARNOLDI E BARNI S GALLO L PESSI MA GUGLIELMI A TURCI D CORTESI E MILANDRI C ASCHELE C GROSSI F LABIANCA R
Citation: A. Sobero et al., RANDOMIZED COMPARISON BETWEEN SEQUENTIAL MTX-]FU AND SCHEDULE SPECIFIC BIOCHEMICAL MODULATION IN ADVANCED COLORECTAL-CANCER (ACRC), Annals of oncology, 9, 1998, pp. 157-157
FUDR ALONE OR IN COMBINATION WITH SYSTEMIC CHEMOTHERAPY (CT) IN LIVERMETASTASES FROM COLORECTAL-CANCER (CRC) - PRELIMINARY-RESULTS OF A RANDOMIZED GISCAD-SITILO TRIAL
Authors: PANCERA G FIORENTINI GM TUMOLO S BARNI S CERAVOLO C CORTESI E DALLAVALLE G COMELLA P MASSIDDA B CIRILLO F ANDREONI B MONTINARI F ZAMPARELLI G LABIANCA R VAGLINI M LUPORINI G
Citation: G. Pancera et al., FUDR ALONE OR IN COMBINATION WITH SYSTEMIC CHEMOTHERAPY (CT) IN LIVERMETASTASES FROM COLORECTAL-CANCER (CRC) - PRELIMINARY-RESULTS OF A RANDOMIZED GISCAD-SITILO TRIAL, Annals of oncology, 9, 1998, pp. 158-158
ADJUVANT CHEMOTHERAPY WITH PELF IN OPERABLE GASTRIC-CANCER - (STAGE IB, II, IIIA-B AND IV T4N2MO)
Authors: DICOSTANZO F GASPERONI S CARLINI P TONATO M LABIANCA R BRAVI S FORNARINI G BISAGNI G SDROBOLINI A MANZIONE L
Citation: F. Dicostanzo et al., ADJUVANT CHEMOTHERAPY WITH PELF IN OPERABLE GASTRIC-CANCER - (STAGE IB, II, IIIA-B AND IV T4N2MO), Annals of oncology, 9, 1998, pp. 252-252
GEMCITABINE (GEM) PLUS VINORELBINE (NVB) IN NONSMALL CELL LUNG-CANCER(NSCLC)
Authors: MICHETTI G BERETTA GD BELOMETTI MO GRITTI G MARINI B AGAZZI A LABIANCA R
Citation: G. Michetti et al., GEMCITABINE (GEM) PLUS VINORELBINE (NVB) IN NONSMALL CELL LUNG-CANCER(NSCLC), Annals of oncology, 9, 1998, pp. 440-440
OXALIPLATIN AS SINGLE-AGENT IN PREVIOUSLY UNTREATED COLORECTAL-CARCINOMA PATIENTS - A PHASE-II MULTICENTRIC STUDY
Authors: DIAZRUBIO E SASTRE J ZANIBONI A LABIANCA R CORTESFUNES H DEBRAUD F BONI C BENAVIDES M DALLAVALLE G HOMERIN M
Citation: E. Diazrubio et al., OXALIPLATIN AS SINGLE-AGENT IN PREVIOUSLY UNTREATED COLORECTAL-CARCINOMA PATIENTS - A PHASE-II MULTICENTRIC STUDY, Annals of oncology, 9(1), 1998, pp. 105-108
AN INTERNATIONAL MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER (FIRST OF 2 PARTS) (REPRINTED FROM EUR-J-SURG-ONCOL, VOL 23, SUPPL A, AUGUST 1997)
Authors: BAKER J BLEIBERG H HUTCHISON G JACKMAN A KERR D LABIANCA R MACDONALD J MEYER HJ MINSKY B NORDLINGER B ROUGIER P SMITS S SOBRERO A TAYLOR I VERWEIJ J
Citation: J. Baker et al., AN INTERNATIONAL MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER (FIRST OF 2 PARTS) (REPRINTED FROM EUR-J-SURG-ONCOL, VOL 23, SUPPL A, AUGUST 1997), Annales chirurgiae et gynaecologiae, 87(3), 1998, pp. 255-264
EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG
Authors: WILS J SAHMOUD T SOBRERO A BLEIBERG H AHMEDZAI S BLAZEBY J BLIJHAM G CONROY T CUNNINGHAM D CURRAN D DIAZRUBIO E DUCREUX M EVANS J GLIMELIUS B HUTCHINSON G KERR D KIEBERT G KOHNE H LABIANCA R LANGENDIJK R NITTI D NORDLINGER B ROUGIER P SCHEITHAUER W SCHMOLL HJ VANCUTSEM E WAGENER T WILKE J MARINUS A THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: ROUGIER P VANCUTSEM E BAJETTA E NIEDERLE N POSSINGER K LABIANCA R NAVARRO M MORANT R BLEIBERG H WILS J AWAD L HERAIT P JACQUES C
Citation: P. Rougier et al., RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1407-1412
ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL
Authors: ROUGIER P SAHMOUD T NITTI D CURRAN D DOCI R DEWAELE B NAKAJIMA T RAUSCHECKER H LABIANCA R PECTOR JC MARSONI S APOLONE G LASSER P COUVREUR ML WILS J
Citation: P. Rougier et al., ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL, Lancet, 351(9117), 1998, pp. 1677-1681
GIVIO-SITAC-01 - A RANDOMIZED TRIAL OF ADJUVANT 5-FLUOROURACIL AND FOLINIC ACID ADMINISTERED TO PATIENTS WITH COLON-CARCINOMA - LONG-TERM RESULTS AND EVALUATION OF THE INDICATORS OF HEALTH-RELATED QUALITY-OF-LIFE
Authors: ZANIBONI A LABIANCA R MARSONI S TORRI V MOSCONI P GRILLI R APOLONE G CIFANI S TINAZZI A
Citation: A. Zaniboni et al., GIVIO-SITAC-01 - A RANDOMIZED TRIAL OF ADJUVANT 5-FLUOROURACIL AND FOLINIC ACID ADMINISTERED TO PATIENTS WITH COLON-CARCINOMA - LONG-TERM RESULTS AND EVALUATION OF THE INDICATORS OF HEALTH-RELATED QUALITY-OF-LIFE, Cancer, 82(11), 1998, pp. 2135-2144
INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD)
Authors: CASCINU S LABIANCA R GRAZIANO F PANCERA G BARNI S FRONTINI L LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD), British Journal of Cancer, 78(3), 1998, pp. 390-393
SCHEDULE-SELECTIVE BIOCHEMICAL MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - A MULTICENTRIC PHASE-II STUDY
Authors: ASCHELE C GUGLIELMI A FRASSINETI GL MILANDRI C AMADORI D LABIANCA R VINCI M TIXI L CAROTI C CIFERRI E VERDI E ROSSO R SOBRERO A
Citation: C. Aschele et al., SCHEDULE-SELECTIVE BIOCHEMICAL MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - A MULTICENTRIC PHASE-II STUDY, British Journal of Cancer, 77(2), 1998, pp. 341-346
GEMCITABINE (GEM) AND 5-FLUOROURACIL (5 FU) IN ADVANCED PANCREATIC-CANCER - A GISCAD PHASE-II STUDY
Authors: CASCINU S FRONTINI L LABIANCA R SILVA R FERRETTI B BARNI S CATALANO G CELLERINO R
Citation: S. Cascinu et al., GEMCITABINE (GEM) AND 5-FLUOROURACIL (5 FU) IN ADVANCED PANCREATIC-CANCER - A GISCAD PHASE-II STUDY, European journal of cancer, 33, 1997, pp. 1268-1268
SHOULD PATIENTS WITH ADVANCED COLORECTAL-CANCER BE TREATED WITH CHEMOTHERAPY - CONTRA
Authors: LABIANCA R
Citation: R. Labianca, SHOULD PATIENTS WITH ADVANCED COLORECTAL-CANCER BE TREATED WITH CHEMOTHERAPY - CONTRA, European journal of cancer, 33(6), 1997, pp. 818-822
GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE
Authors: BLEIBERG H GERARD B WILS J BLIJHAM G DIAZRUBIO E HERRMANN R KERR D LABIANCA R ROUGIER P WILKE HJ WILKING N
Citation: H. Bleiberg et al., GASTROINTESTINAL-TRACT CANCER LIAISON OFFICE - AN ATTEMPT TO ORGANIZECLINICAL RESEARCH IN EUROPE, European journal of cancer, 33(10), 1997, pp. 1536-1545
EVALUATION OF FACTORS INFLUENCING 5-FLUOROURACIL-INDUCED DIARRHEA IN COLORECTAL-CANCER PATIENTS - AN ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD) STUDY
Authors: CASCINU S BARNI S LABIANCA R DELFERRO E ROCCHI MBL LIGI M PESSI MA CAZZANIGA M ZAMPARELLI G ARDIZZOIA A UGOLINI G GHIANDONI G LUPORINI G CATALANO G
Citation: S. Cascinu et al., EVALUATION OF FACTORS INFLUENCING 5-FLUOROURACIL-INDUCED DIARRHEA IN COLORECTAL-CANCER PATIENTS - AN ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD) STUDY, Supportive care in cancer, 5(4), 1997, pp. 314-317
HIGH-DOSE VERSUS LOW-DOSE LEVO-LEUCOVORIN AS A MODULATOR OF 5-FLUOROACIL IN ADVANCED COLORECTAL-CANCER - A GISCAD PHASE-III STUDY
Authors: LABIANCA R CASCINU S FRONTINI L BARNI S FIORENTINI G COMELLA G ZANIBONI A GOTTARDI O ARNOLDI E OLIANI C DURO M PAVANATO G MARTIGNONI G RAINA A PIAZZA E DALLAVALLE G VALSECCHI R PANCERA G LUPORINI G
Citation: R. Labianca et al., HIGH-DOSE VERSUS LOW-DOSE LEVO-LEUCOVORIN AS A MODULATOR OF 5-FLUOROACIL IN ADVANCED COLORECTAL-CANCER - A GISCAD PHASE-III STUDY, Annals of oncology, 8(2), 1997, pp. 169-174
BIOLOGICAL INDEXES PREDICTIVE OF SURVIVAL IN 519 ITALIAN TERMINALLY ILL CANCER-PATIENTS
Authors: MALTONI M PIROVANO M NANNI O MARINARI M INDELLI M GRAMAZIO A TERZOLI E LUZZANI M DEMARINIS F CARACENI A LABIANCA R SCARPI E INNOCENTI MP VINCI M CENTRONE G MARZOLA M GIACCON G ARNOLDI E GALLUCCI M FRONTINI L PIVA L ZANINETTA G PETRELLA V BARNI S BERETTA G CALIA C MORO G CARDAMONE I GROFF L AMADORI D
Citation: M. Maltoni et al., BIOLOGICAL INDEXES PREDICTIVE OF SURVIVAL IN 519 ITALIAN TERMINALLY ILL CANCER-PATIENTS, Journal of pain and symptom management, 13(1), 1997, pp. 1-9
INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER
Authors: CASCINU S LABIANCA R ALESSANDRONI P MARCELLINI M SILVA RR PANCERA G TESTA E MARTIGNONI G BARNI S FRONTINI L ZANIBONI A LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3313-3319
TREATMENT OF COLORECTAL-CANCER - CURRENT GUIDELINES AND FUTURE-PROSPECTS FOR DRUG-THERAPY - DRUGS (VOL 53, PG 593, 1997)
Authors: LABIANCA R PESSI MA ZAMPARELLI G
Citation: R. Labianca et al., TREATMENT OF COLORECTAL-CANCER - CURRENT GUIDELINES AND FUTURE-PROSPECTS FOR DRUG-THERAPY - DRUGS (VOL 53, PG 593, 1997), Drugs, 54(1), 1997, pp. 160-160
TREATMENT OF COLORECTAL-CANCER - CURRENT GUIDELINES AND FUTURE-PROSPECTS FOR DRUG-THERAPY
Authors: LABIANCA R PESSI MA ZAMPARELLI G
Citation: R. Labianca et al., TREATMENT OF COLORECTAL-CANCER - CURRENT GUIDELINES AND FUTURE-PROSPECTS FOR DRUG-THERAPY, Drugs, 53(4), 1997, pp. 593-607
SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL AS 2ND-LINE CHEMOTHERAPY FOR ADVANCED COLORECTAL-CANCER PATIENTS PRETREATED WITH 5-FLUOROURACIL AND LEUCOVORIN - A GISCAD STUDY
Authors: ZANIBONI A LABIANCA R MARTIGNONI G BARNI S VINCI M VAGHI M PIROVANO M FACENDOLA G MARINI G LUPORINI G
Citation: A. Zaniboni et al., SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL AS 2ND-LINE CHEMOTHERAPY FOR ADVANCED COLORECTAL-CANCER PATIENTS PRETREATED WITH 5-FLUOROURACIL AND LEUCOVORIN - A GISCAD STUDY, Journal of chemotherapy, 8(1), 1996, pp. 82-84
MODULATED 5-FLUOROURACIL (5-FU) REGIMENS IN ADVANCED COLORECTAL-CANCER - A CRITICAL-REVIEW OF COMPARATIVE-STUDIES
Authors: LABIANCA R PESSI A FACENDOLA G PIROVANO M LUPORINI G
Citation: R. Labianca et al., MODULATED 5-FLUOROURACIL (5-FU) REGIMENS IN ADVANCED COLORECTAL-CANCER - A CRITICAL-REVIEW OF COMPARATIVE-STUDIES, European journal of cancer, 32A, 1996, pp. 7-12
CISPLATIN-ASSOCIATED ANEMIA IN PATIENTS WITH SOLID TUMORS - A RETROSPECTIVE EVALUATION AND CONSIDERATIONS RELATIVE TO ERYTHROPOIETIN ADMINISTRATION
Authors: LOCATELLI MC TEDESCHI L CLERICI M ROMANELLI A DANTONA A LABIANCA R LUPORINI G
Citation: Mc. Locatelli et al., CISPLATIN-ASSOCIATED ANEMIA IN PATIENTS WITH SOLID TUMORS - A RETROSPECTIVE EVALUATION AND CONSIDERATIONS RELATIVE TO ERYTHROPOIETIN ADMINISTRATION, Supportive care in cancer, 4(3), 1996, pp. 218-219
Risultati: 1-25 | 26-42